Treace Medical Concepts (TMCI) Gross Profit (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Gross Profit for 7 consecutive years, with $35.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit fell 5.68% year-over-year to $35.6 million; the trailing twelve-month figure through Jun 2026 stood at $163.1 million (down 4.75% YoY), and the FY2025 full-year result was $169.8 million, up 0.88% from the prior year.
• Gross Profit retreated to $35.6 million in Q2 2026 per TMCI's latest filing, from $37.4 million in the prior quarter.
• Across five years, Gross Profit topped out at $55.5 million in Q4 2024 and bottomed at $23.9 million in Q1 2022.
• Historically, Gross Profit has averaged $37.7 million across 5 years, with a median of $36.8 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Gross Profit jumped 55.51% in 2022, then slipped 10.71% in 2026.
• Over 5 years, Gross Profit stood at $40.7 million in 2022, then grew by 24.53% to $50.7 million in 2023, then rose by 9.33% to $55.5 million in 2024, then slipped by 9.15% to $50.4 million in 2025, then declined by 29.35% to $35.6 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $35.6 million, $37.4 million, and $50.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.